http://www.fpnotebook.com/
AminoglycosideAka: Gentamicin, Garamycin
- Pharmacokinetics
- Maintain Trough <2 ug/ml
- Drawn immediately before next dose
- Maintain Peak at 5-8 ug/ml (4-6 ug/ml for child)
- Draw 1 hour after Intramuscular dose
- Indications for pharmacokinetics followed by PharmD
- Aminoglycoside use over 3 days
- Renal dysfunction
- Maintain Trough <2 ug/ml
- Precautions
- Administer IV dose over 1 hour
- Adjust dosing per kinetics if >1-2 days use
- Dosing: Infants
- Term Infant
- Gentamycin 2.5 mg/kg/dose IV or IM q8 hours
- Preterm Infant
- Gestational Age >34 weeks and Weight over 2000 grams
- Gentamycin 2.5 mg/kg/dose IV or IM q12 hours
- Gestational Age <34 weeks
- Weight over 1250 grams
- Gentamycin 2.5 mg/kg/dose IV or IM q18 hours
- Weight Under 1250 grams
- Gentamycin 2.5 mg/kg/dose IV or IM q24 hours
- Weight over 1250 grams
- Age >7 days
- Gentamycin 2.5 mg/kg/dose IV or IM q12 hours
- Gestational Age >34 weeks and Weight over 2000 grams
- Renal Impairment Adjustments
- Serum Creatinine 0.7 to 1.1
- Gentamycin 2.5 mg/kg/dose IV or IM q24 hours
- Serum Creatinine 1.1 to 1.3
- Gentamycin 2.5 mg/kg/dose IV or IM q36 hours
- Serum Creatinine > 1.3
- Gentamycin 2.5 mg/kg/dose IV or IM q48 hours
- Serum Creatinine 0.7 to 1.1
- Term Infant
- Dosing: Children and adults
- Child
- Gentamicin 2 to 2.5 mg/kg IV or IM q8 hours
- Gentamicin 4.5 mg/kg IV q24 hours
- Adults
- Gentamicin 1-1.5 mg/kg IV or IM q8 hours or
- Gentamicin 5-7 mg/kg IV q24 hours
- Child
- Risk Factors for Nephrotoxicity
- Advanced age
- Prior renal insufficiency
- Dehydration
- Hypokalemia
- Hypomagnesemia
- Liver disease
- Sepsis
- Drug interactions with other nephrotoxic medications
- Cephalothin (Keflin) and other Cephalosporins
- Cyclosporin A
- Cisplatin
- NSAIDS
- ACE Inhibitors
- Methoxyflurane
- Loop Diuretics
- Amino acids
Antibiotics, Aminoglycoside (C0003233) | |
|---|---|
| Definition (CSP) | any of a group of antibiotics derived from various species of Streptomyces or produced synthetically; they inhibit protein synthesis by binding with the 30S ribosomal subunit. |
| Definition (NCI) | A family of antibiotics that works against many types of bacteria and includes streptomycin, gentamicin, and neomycin. Aminoglycosides are used to treat bacterial infections. |
| Definition (NCI) | A broad spectrum antibiotic family derived from Streptomyces containing aminoglycosides that bind to bacterial ribosomes, inhibiting protein synthesis. |
| Concepts | Carbohydrate (T118) , Antibiotic (T195) |
| English | Aminoglycoside -class of antibiotic-, Aminoglycoside Agents, aminoglycoside antibiotic, aminoglycoside antibiotics, Aminoglycoside Drugs, Aminoglycosides |
| Parent Concepts | Antibiotics (C0003232), Glycosides (C0017977), Protein Synthesis Inhibitors (C0033671), Anti-Bacterial Agents (C0279516), Drug allergen (C1320237) |
| Sources | AOD, CSP, MTH, NCI, SCTSPA, SNOMEDCT Derived from the NIH UMLS (Unified Medical Language System) |
Gentamicin Sulfate (USP) (C0546866) | |
|---|---|
| Definition (MSH) | A complex antibiotic substance produced by MICROMONOSPORA purpurea, with three components: gentamicin C1 (Gentamicin sulfate (salt)); gentamicin C2 (Gentamicin sulfate); and gentamicin C1A. |
| Concepts | Carbohydrate (T118) , Antibiotic (T195) |
| MSH | D005839 |
| English | Gentamicin, Gentamicin Sulfate, GENTAMICIN SULFATE PREPARATION, Gentamicin sulphate, Gentamycin, GENTAMYCIN SULFATE, Gentamycin sulphate |
| Spanish | sulfato de gentamicina |
| Parent Concepts | Anti-Bacterial Agents (C0279516), Gentamicins (C0017436), Duplicate concept (C1274013), Medicament patch test product (C1445114) |
| Sources | MSH, MTH, MTHFDA, MTHSPL, NCI, NDFRT, RXNORM, SCTSPA, SNOMEDCT, USPMG, VANDF Derived from the NIH UMLS (Unified Medical Language System) |
Garamycin (C0699088) | |
|---|---|
| Concepts | Carbohydrate (T118) , Antibiotic (T195) |
| MSH | D005839 |
| English | Garamycin |
| Sources | MSH, NCI, PDQ, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
